Stock

Lexicon Pharmaceuticals, Inc. LXRX

Market data for LXRX is refreshing — check back shortly.

All stocks Create account to unlock

Overview

LXRX market data

Price History

No market bars yet for LXRX. This page will populate once the next provider sweep lands.

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for LXRX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions · Jun 3, 2026, 12:15 PM

Navigating Life with Hypertrophic Cardiomyopathy · May 14, 2026, 6:15 PM

Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.1 · May 11, 2026, 3:11 PM

8-K filing — LEXICON PHARMACEUTICALS, INC. (LXRX) · May 7, 2026, 11:31 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock